Article
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia.
Blood advances - 10 Dec 2024
Vijenthira Abi, Volpe Virginia O, Sekar Aswin, Santos Azevedo Roberta, Mikhaleva Mariia, Gibson Christopher J, Martindale Stephen P, Fardoun Rayan, Tyekucheva Svitlana, Ren Yue, Fernandes Stacey M, Knisbacher Binyamin A, Hahn Cynthia K, Getz Gad, Wu Catherine J, Davids Matthew S, Brown Jennifer R
Abstract excerpt
ABSTRACT: Clonal hematopoiesis of indeterminate potential (CHIP) in patients with chronic lymphocytic leukemia (CLL) has not been extensively characterized. The objective of this study was to describe the prevalence of myeloid CHIP (M-CHIP) in patients with CLL, and to determine its association with time to first treatment (TTFT) and overall survival (OS). We retrospectively analyzed data from patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
